首页> 外文OA文献 >Low-Frequency Low-Intensity Ultrasounds Do Not Influence the Survival and Immune Functions of Cultured Keratinocytes and Dendritic Cells
【2h】

Low-Frequency Low-Intensity Ultrasounds Do Not Influence the Survival and Immune Functions of Cultured Keratinocytes and Dendritic Cells

机译:低频低强度超声不影响培养的角质形成细胞和树突状细胞的存活和免疫功能

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Low-frequency ultrasounds (US) are used to enhance drug transdermal transport. Although this phenomenon has been extensively analyzed, information on US effects on the single skin cell components is limited. Here, we investigated the possible effects of low-frequency US on viability and immune functions of cultured human keratinocytes and dendritic cells (DC), skin cells involved in the regulation of many immune-mediated dermatoses. We demonstrated that US, employed at low-frequency (42 KHz) and low-intensity (0.15 W/cm2) values known to enhance drug and water transdermal transport, did not affect extracellular-signal-regulated-kinase (ERK)1/2 activation, cell viability, or expression of adhesion molecules in cultured keratinocytes. Moreover, US at these work frequency and intensity did not influence the keratinocyte expression and release of immunomodulatory molecules. Similarly, cultured DC treated with low-frequency low-intensity US were viable, and did not show an altered membrane phenotype, cytokine profile, nor antigen presentation ability. However, intensity enhancement of low-frequency US to 5 W/cm2 determined an increase of the apoptotic rate of both keratinocytes and DC as well as keratinocyte CXCL8 release and ERK1/2 activation, and DC CD40 expression. Our study sustains the employment of low-frequency and low-intensity US for treatment of those immune skin disorders, where keratinocytes and DC have a pathogenetic role.
机译:低频超声(US)用于增强药物的透皮运输。尽管已经对该现象进行了广泛分析,但有关美国对单个皮肤细胞成分的影响的信息仍然有限。在这里,我们调查了低频超声对培养的人类角质形成细胞和树突状细胞(DC)(参与调节许多免疫介导的皮肤病的皮肤细胞)的活力和免疫功能的可能影响。我们证明,以低频(42 KHz)和低强度(0.15 W / cm2)值使用的美国已知能增强药物和水的透皮运输,不会影响细胞外信号调节激酶(ERK)1/2活化,细胞活力或培养的角质形成细胞中粘附分子的表达。此外,在这些工作频率和强度下,US不会影响角质形成细胞的表达和免疫调节分子的释放。同样,用低频低强度US处理的培养DC是可行的,并且没有显示改变的膜表型,细胞因子谱或抗原呈递能力。然而,低频超声强度增强至5 W / cm2决定了角质形成细胞和DC以及角质形成细胞CXCL8释放和ERK1 / 2活化以及DC CD40表达的凋亡率增加。我们的研究支持使用低频低强度US来治疗那些免疫性皮肤病,其中角质形成细胞和DC具有致病作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号